RCMI Coordinating Center (RCMI CC) Header Logo

Askal Ali

TitleDr.
Faculty RankAssociate Professor
InstitutionFlorida A&M University
DepartmentCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
AddressFlorida A&M University
1415 S Martin Luther King Jr. Blvd.
Tallahassee FL 32307
Phone+18505993082
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abegaz TM, Frietze G, Bhagavathula AS, Ali AA. Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved Ejection Fraction and Obesity. JACC Heart Fail. 2026 Apr 17; 103060. PMID: 42012431.
      Citations:    
    2. Gbogbo D, Tawk R, Ali AA, Reyes-Ortiz CA, Kiros GE. Impact of Pre-Diagnosed Depressive Symptoms on Treatment Choice, Delay in Initiating Treatment, and Mortality Among Women Aged =65 Years with Breast Cancer. Int J Environ Res Public Health. 2026 Mar 12; 23(3). PMID: 41899738.
      Citations:    
    3. Baljoon A, Diaby V, Suther S, Dutton M, Ali A, Eljilany I. Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States. Pharmacoecon Open. 2026 May; 10(3):457-469. PMID: 41790421.
      Citations:    
    4. Nkemdirim Okere A, Li T, Islam MM, Ali AA, Buxbaum SG, Diaby V. Development of machine learning models to predict risk of hospitalisation and 90-day readmission among patients with cardiovascular risk factors using community health survey data. BMJ Health Care Inform. 2025 Dec 31; 32(1). PMID: 41475883.
      Citations:    
    5. Nkemdirim Okere A, Moussa RK, Ali AA, Li T, Buxbaum SG, Diaby V. Patient-reported outcomes and perceived medication confidence as predictors of healthcare utilization among adults with cardiovascular risk factors. Sci Rep. 2025 Dec 05; 16(1):1427. PMID: 41350604.
      Citations:    
    6. Luque JS, Kiros GE, Ali AA, Dickey SL, Vargas M, Jackson DR, Mohorne R, Doddi T, Wallace K, Gwede CK. Monitoring of Colorectal Cancer Screening Adherence Among African American Patients of North Florida Community Health Centers. J Cancer Educ. 2025 Oct 24. PMID: 41134442.
      Citations:    
    7. Adjei K, Diaby V, Li M, Sherbeny F, Suther S, Ali AA. A systematic review of the applications of the real option value of medical technologies in oncology. J Manag Care Spec Pharm. 2025 Oct; 31(10):1062-1074. PMID: 41004207.
      Citations:    
    8. Luque JS, Kiros GE, Vargas MA, Ali A, Tawk R, Jackson DR, Dickey SL, Harris CM, Robinson T, Duncan B, Freeman J, Gwede CK, Wallace K. Effectiveness of a community health advisor colorectal cancer screening educational intervention on stool test completion in an African American primary care patient population: a pragmatic randomized controlled trial. BMC Glob Public Health. 2025 Jun 01; 3(1):47. PMID: 40450376.
      Citations:    
    9. Nkemdirim Okere A, Li T, Theran C, Nyasani E, Ali AA. Evaluation of factors predicting transition from prediabetes to diabetes among patients residing in underserved communities in the United States - A machine learning approach. Comput Biol Med. 2025 Mar; 187:109824. PMID: 39933273.
      Citations: 1     Fields:    Translation:Humans
    10. Abegaz TM, Ahmed M, Ali AA, Bhagavathula AS. Predicting Health-Related Quality of Life Using Social Determinants of Health: A Machine Learning Approach with the All of Us Cohort. Bioengineering (Basel). 2025 Feb 09; 12(2). PMID: 40001685.
      Citations:    
    11. Ali AA, Kulkarni A, Bhattacharjee S, Diaby V. Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. Pharmacoeconomics. 2024 Jul; 42(Suppl 2):211-224. PMID: 38758291.
      Citations: 1     Fields:    Translation:Humans
    12. Adunlin G, Skiera J, Cupp CS, Ali AA, Afeli SAY. The State of Pharmacoeconomics Education in the Doctor of Pharmacy Curriculum amid the Changing Face of Pharmacy Practice. Healthcare (Basel). 2023 Nov 08; 11(22). PMID: 37998415.
      Citations:    
    13. Zhang X, Dutton M, Liu R, Ali AA, Sherbeny F. Deep Learning-Based Survival Analysis for Receiving a Steatotic Donor Liver Versus Waiting for a Standard Liver. Transplant Proc. 2023 Dec; 55(10):2436-2443. PMID: 37872066.
      Citations:    Fields:    Translation:Humans
    14. Nkemdirim Okere A, Moussa RK, Ali A, Diaby VK. Development and validation of a tool to predict high-need, high-cost patients hospitalised with ischaemic heart disease. BMJ Open. 2023 09 26; 13(9):e073485. PMID: 37751949.
      Citations:    Fields:    Translation:Humans
    15. Abegaz TM, Baljoon A, Kilanko O, Sherbeny F, Ali AA. Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes. Comput Biol Med. 2023 09; 164:107289. PMID: 37557056.
      Citations: 9     Fields:    Translation:Humans
    16. Luque JS, Kiros GE, Vargas M, Jackson DR, Matthew OO, Austin TD, Tawk R, Ali AA, Harris CM, Wallace K, Gwede CK. Association of Preventive Care Attitudes and Beliefs with Colorectal Cancer Screening History among African American Patients of Community Health Centers. J Cancer Educ. 2023 12; 38(6):1816-1824. PMID: 37442915.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    17. Abegaz TM, Ahmed M, Sherbeny F, Diaby V, Chi H, Ali AA. Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program Data. Healthcare (Basel). 2023 Apr 15; 11(8). PMID: 37107973.
      Citations:    
    18. Matyori A, Brown CP, Ali A, Sherbeny F. Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines. Saudi Pharm J. 2023 Jun; 31(6):795-800. PMID: 37228328.
      Citations:    
    19. Adjei K, Adunlin G, Ali AA. Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder. Healthcare (Basel). 2023 Mar 03; 11(5). PMID: 36900745.
      Citations:    
    20. Abegaz TM, Ali AA. Health-Related Quality of Life and Healthcare Events in Patients with Monotherapy of Anti-Diabetes Medications. Healthcare (Basel). 2023 Feb 12; 11(4). PMID: 36833075.
      Citations:    
    21. Alotaibi A, Ali A, Brown C, Sherbeny F. Exploratory Analysis of Survival and Mortality Rates among Older Lung Cancer Patients Utilizing Different Treatment Modalities. Innov Pharm. 2022; 13(2). PMID: 36654704.
      Citations:    
    22. Abegaz TM, Diaby V, Sherbeny F, Ali AA. Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA. Clin Drug Investig. 2022 Jun; 42(6):501-511. PMID: 35614298.
      Citations: 6     Fields:    Translation:Humans
    23. Ali AA, Tawk R, Xiao H, Semykina A, Montero AJ, Moussa RK, Popoola O, Diaby V. Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer. Expert Rev Pharmacoecon Outcomes Res. 2022 Jul; 22(5):735-741. PMID: 35189767.
      Citations: 3     Fields:    Translation:Humans
    24. Luque JS, Matthew OO, Jackson DR, Vargas MA, Austin T, Ali A, Kiros GE, Harris CM, Tawk R, Gwede CK, Wallace K, Jean-Pierre P. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial. Trials. 2022 Feb 15; 23(1):151. PMID: 35168640.
      Citations: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    25. Diaby V, Ali A, Babcock A, Fuhr J, Braithwaite D. Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions. J Manag Care Spec Pharm. 2021 Sep; 27(9-a Suppl):S22-S29. PMID: 34579542.
      Citations: 7     Fields:    Translation:Humans
    26. Luque JS, Vargas M, Wallace K, Matthew OO, Tawk R, Ali AA, Kiros GE, Harris CM, Gwede CK. Engaging the Community on Colorectal Cancer Screening Education: Focus Group Discussions Among African Americans. J Cancer Educ. 2022 04; 37(2):251-262. PMID: 33904120.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    27. Diaby V, Almutairi RD, Babcock A, Moussa RK, Ali A. Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert Rev Pharmacoecon Outcomes Res. 2021 Jun; 21(3):353-364. PMID: 33213205.
      Citations: 2     Fields:    Translation:Humans
    28. Babcock A, Ali AA, Balkrishnan R, Montero A, Diaby V. Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary. J Manag Care Spec Pharm. 2020 Jul; 26(7):826-831. PMID: 32584682.
      Citations: 7     Fields:    Translation:Humans
    29. Diaby V, Wang CY, Alqhtani H, van Boemmel-Wegmann S, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting. Data Brief. 2020 Apr; 29:105194. PMID: 32071975.
      Citations:    
    30. Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. Breast. 2020 Feb; 49:141-148. PMID: 31805500.
      Citations: 8     Fields:    Translation:Humans
    31. Xiao H, Jiang X, Chen C, Wang W, Wang CY, Ali AA, Berthe A, Moussa RK, Diaby V. Using time series analysis to forecast the health-related quality of life of post-menopausal women with non-metastatic ER+ breast cancer: A tutorial and case study. Res Social Adm Pharm. 2020 Aug; 16(8):1095-1099. PMID: 31753693.
      Citations: 1     Fields:    Translation:Humans
    32. Diaby V, Ali AA, Montero AJ. Value Assessment Frameworks in the United States: A Call for Patient Engagement. Pharmacoecon Open. 2019 Mar; 3(1):1-3. PMID: 30182346.
      Citations:    
    33. Ali AA, Tawk R, Xiao H, Campbell E, Semykina A, Montero AJ, Mogos M, Diaby V. Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data. Cancer Med. 2019 01; 8(1):117-127. PMID: 30548840.
      Citations: 7     Fields:    Translation:Humans
    34. Dong J, Reeves L, Ali A, Freeman MK, Adunlin G. A Systematic Review of the Effectiveness of Text Message Reminders on Asthma Medication Adherence. Innov Pharm. 2018; 9(3):1-7. PMID: 34007710.
      Citations:    
    35. Queeley GL, Campbell ES, Ali AA. Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States. Am Health Drug Benefits. 2018 Jul; 11(5):223-230. PMID: 30464791.
      Citations:    
    36. Diaby V, Ali AA, Williams KJ, Ezendu K, Soto-Perez-de-Celis E, Chavarri-Guerra Y, de Lima Lopes G. Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives. Breast Cancer Res Treat. 2017 Dec; 166(3):951-963. PMID: 28840424.
      Citations: 9     Fields:    Translation:Humans
    37. Ali AA, Xiao H, Tawk R, Campbell E, Semykina A, Montero AJ, Diaby V. Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy. Curr Med Res Opin. 2017 02; 33(2):391-400. PMID: 27819160.
      Citations: 7     Fields:    Translation:Humans
    38. Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ. Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):187-196. PMID: 27654970.
      Citations: 20     Fields:    Translation:Humans
    39. Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ. Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients. Curr Med Res Opin. 2016 06; 32(6):991-6. PMID: 26824145.
      Citations: 6     Fields:    Translation:Humans
    40. Goovaerts P, Xiao H, Gwede CK, Tan F, Huang Y, Adunlin G, Ali A. Impact of Age, Race and Socio-economic Status on Temporal Trends in Late-Stage Prostate Cancer Diagnosis in Florida. Spat Stat. 2015 Nov 01; 14(Pt 100):321-337. PMID: 26644992.
      Citations:    
    41. Goovaerts P, Xiao H, Adunlin G, Ali A, Tan F, Gwede CK, Huang Y. GEOGRAPHICALLY-WEIGHTED REGRESSION ANALYSIS OF PERCENTAGE OF LATE-STAGE PROSTATE CANCER DIAGNOSIS IN FLORIDA. Appl Geogr. 2015 Aug 01; 62:191-200. PMID: 26257450.
      Citations:    
    42. Xiao H, Tan F, Adunlin G, Ali AA, Goovaerts P, Gwede CK, Huang Y. Factors associated with overall survival prostate cancer in Florida: a multilevel analysis. J Health Care Poor Underserved. 2015 Feb; 26(1):266-77. PMID: 25702742.
      Citations: 1     Fields:    Translation:Humans
    43. Xiao H, Tan F, Goovaerts P, Adunlin G, Ali AA, Gwede CK, Huang Y. Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida. Am J Mens Health. 2016 07; 10(4):285-95. PMID: 25542838.
      Citations: 8     Fields:    Translation:Humans
    44. Diaby V, Adunlin G, Ali AA, Tawk R. Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial. Breast Cancer Res Treat. 2014 Aug; 146(3):669-73. PMID: 25017612.
      Citations: 9     Fields:    Translation:Humans
    45. Ali AA, Xiao H, Kiros GE. Health insurance and breast-conserving surgery with radiation treatment. Am J Manag Care. 2014 Jun; 20(6):502-16. PMID: 25180437.
      Citations: 6     Fields:    Translation:Humans
    46. Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Gwede CK, Huang Y. Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida. Am J Mens Health. 2014 Jul; 8(4):316-26. PMID: 24297455.
      Citations: 4     Fields:    Translation:Humans
    47. Xiao H, Tan F, Goovaerts P, Adunlin G, Ali A, Huang Y, Gwede CK. Factors associated with time-to-treatment of prostate cancer in Florida. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):132-46. PMID: 24241267.
      Citations: 5     Fields:    Translation:Humans
    48. Xiao H, Tan F, Goovaerts P, Adunlin G, Ali AA, Gwede CK, Huang Y. Use of treatment information from a state central cancer registry in prostate cancer research. J Registry Manag. 2013; 40(3):127-30. PMID: 24643215.
      Citations: 1     Fields:    Translation:Humans
    49. Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Huang Y, Gwede C. Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data. J Registry Manag. 2013; 40(4):159-64. PMID: 24625768.
      Citations: 7     Fields:    Translation:Humans
    Ali's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (121)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support